Results 61 to 70 of about 5,438 (215)

The effects of croscarmellose sodium concentration on the physicochemical characteristics of orodispersible tablets of atenolol [PDF]

open access: yes, 2018
Hypertension is the most common cardiovascular diseases suffered by geriatric patients. Their physiological changes make the administration of conventional tablets less effective, especially regarding compliance.
Parfati, Nani, Rani, Karina Citra
core   +2 more sources

Inhibition of the NLRP3 Inflammasome With MCC950 Improves Gut Health in Huntington's Disease Mice

open access: yesJournal of Neurochemistry, Volume 170, Issue 4, April 2026.
The NLRP3 inflammasome in HD (Huntington's disease) peripheral pathology (in gastrointestinal complications) is vastly unexplored. In this preclinical study, non‐invasive readouts of gut function assessment revealed that inhibiting NLRP3 inflammasome by chronic administration of MCC950 by oral route softened the faecal pellets, improved faecal output ...
Sujan Kumar Sarkar   +10 more
wiley   +1 more source

A Translation of Technology: MicroCoat™ to Sustained Release Orally Disintegrating Tablets

open access: yesBritish Journal of Pharmacy, 2022
Orally disintegrating tablets (ODTs) comprising sustained release (SR) coated microparticles smaller than 250 µm provide an appealing dosage form for patients with dysphagia, offering a superior mouthfeel and highly convenient route of administration ...
Kavil Patel   +3 more
doaj   +1 more source

Characterising the disintegration properties of tablets in opaque media using texture analysis. [PDF]

open access: yes, 2015
Tablet disintegration characterisation is used in pharmaceutical research, development, and quality control. Standard methods used to characterise tablet disintegration are often dependent on visual observation in measurement of disintegration times ...
Gerrard, Stephen E   +5 more
core   +3 more sources

Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 3, March 2026.
Abstract Daily oral cyclobenzaprine hydrochloride (HCl) has provided transient benefits in fibromyalgia, a chronic pain condition. To improve this effect, we evaluated sublingual formulations designed to drive transmucosal absorption. Two open‐label studies evaluated the pharmacokinetics (PK), tolerability, and relative bioavailability of sublingual ...
Bruce L Daugherty   +4 more
wiley   +1 more source

Optimizing outcomes in ADHD treatment: From clinical targets to novel delivery systems [PDF]

open access: yes, 2016
Our knowledge and understanding of the underlying neurobiology and symptomatic expression of ADHD has advanced dramatically over the past decade. Associated with these advances has been a similar explosion of new treatment options to individualize ...
Anderson, Richard H   +1 more
core   +2 more sources

Matrix‐Dependent Sweet–Sour Psychophysics: gLMS and Time‐Intensity of Sugar Alcohol‐Acid Mixture in Liquids and Tablets

open access: yesFood Science &Nutrition, Volume 14, Issue 3, March 2026.
Tablets showed > 79% steeper sourness growth than liquids by power law. Malic acid yielded steeper sourness growth than citric acid in most matrices and xylitol matrix yielded balanced perception with near‐unity sourness exponents. Time‐intensity parameters provide actionable targets for controlling sweetness‐sourness balance.
Chenchen Liu   +4 more
wiley   +1 more source

PEARL: Protein Eluting Alginate with Recombinant Lactobacilli

open access: yesSmall, Volume 22, Issue 16, 17 March 2026.
Probiotic lactobacilli meet engineered living materials: This study introduces PEARL (protein eluting alginate with recombinant lactobacilli), an innovative engineered living material combining Lactiplantibacillus plantarum and alginate beads for controlled protein release.
Varun Sai Tadimarri   +7 more
wiley   +1 more source

ORODISPERSIBLE TABLETS – A NOVEL APPROACH

open access: yesGomal Journal of Medical Sciences, 2017
Pharmaceutical technologists have developed a novel oral dosage forms known as orally disintegrating tablets or fast disintegrating tablets or mouth melting tablets or mouth dissolving tablets which disintegrate rapidly in saliva, usually in a matter of ...
Sattar Bakhsh Awan
doaj  

Home - About - Disclaimer - Privacy